How do we determine what a fair price for a life-saving prescription medication should be? This month, we discuss what is means for a price to be “fair” and explore the current legal and economic landscape of prescription drug pricing in the US.
Dr Paul T. Menzel joins Ethics Talk to discuss his article: "How Should Willingness-to-Pay Values of Quality-Adjusted Life-Years Be Updated and According to Whom?"
Debbie Berkowitz joins Ethics Talk to discuss her article, coauthored with Anna D. Goff, Dr Kathleen Marie Fagan, and Dr Monica L. Gerrek: "Do Clinics in Meat and Poultry Plants Endanger Workers?”
Dr Lisa Lehmann joins Ethics Talk to discuss “grateful patient programs,” pressures clinicians face to fundraise on behalf of health care organizations for which they work, and whether “VIP” care really is better for patients.
Dr Kimberly A. Singletary joins Ethics Talk to discuss her article, coauthored with Dr Marshall H. Chin: “What Should Antiracist Payment Reform Look Like?”
Dr Jeremy Weleff joins Ethics Talk to discuss his article, coauthored with Dr Dawn Potter: “Key Updates to Understanding Roles of Childhood Trauma in Overall Health.”
Dr Brent M. Kious joins Ethics Talk to discuss his article, coauthored with Dr Ryan H. Nelson: “Does It Matter Whether a Psychiatric Intervention Is ‘Palliative’?”
